As demand accelerates for simpler, more reliable remote patient monitoring solutions, Smart Meter, the leading supplier of cellular-enabled Remote Patient Monitoring (RPM) devices, data, and services, today announced the launch of iGlucose® Touch, a next-generation blood glucose monitoring system engineered to modernize glucose testing while delivering dependable, real-time data to care teams.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260120102929/en/

Smart Meter's iGlucose Touch cellular-connected blood glucose meter

Purpose-built for RPM, iGlucose Touch addresses long-standing challenges in glucose monitoring by pairing a bright, intuitive touchscreen with Smart Meter’s proprietary cellular connectivity. With every test, accurate blood glucose results are automatically and securely transmitted through Smart Meter’s Private Data Network directly to customers’ RPM platform of choice, eliminating the need for Bluetooth pairing, wifi, apps, and hubs altogether. When combined with Smart Meter’s algorithm-driven direct-to-home auto test strip fulfillment program, patients experience a truly seamless, low-friction experience from testing to care.

“iGlucose Touch represents an important step forward in giving providers and patients more choice in how glucose is monitored,” said Casey Pittock, CEO at Smart Meter. “For many patients, a connected blood glucose meter remains the most practical, affordable, and accurate option. iGlucose Touch modernizes the BGM experience while preserving the simplicity patients and clinicians trust.”

Designed for Simplicity, Built for Reliability

At the center of iGlucose Touch is a responsive 2.8-inch color touchscreen, replacing traditional multi-button navigation with a clean, modern interface designed for ease of use across diverse patient populations. The system supports automatic strip coding, a fast 5-second test time, and memory storage for up to 1,000 readings with date and time stamps. Meal markers and notes can be added to each result, giving care teams richer context when reviewing patient data.

To ensure consistent performance regardless of location, iGlucose Touch uses advanced multicarrier SIM technology, automatically connecting to the strongest available cellular network in the area. This ensures critical readings are transmitted consistently, securely, and without patient intervention, even across varying geographies and coverage conditions, helping to improve health equity and access to care.

High Accuracy You Can Trust

iGlucose Touch delivers clinically reliable performance, with results aligned to laboratory standards. In fingertip testing, 100% of test results were within FDA guidelines. This high level of accuracy supports confident clinical decision-making and sustained patient engagement. iGlucose Touch test strips are inserted horizontally, allowing the blood sample to travel a shorter distance to the sensor module, helping deliver more accurate readings than meters with vertical strip insertion. Each iGlucose Touch device is backed by a 5-year warranty.

Expanding Options for Glucose Monitoring

While continuous glucose monitors (CGMs) play an important role for many patients, they are not the right fit for everyone. Cost, wearability preferences, clinical eligibility, and workflow considerations continue to limit broader adoption. Recent U.S. data show that CGM use remains limited outside of type 1 diabetes specialty populations, often well below 20% of adults with diabetes. Notably, only about 16% of U.S. adults with type 2 diabetes currently use CGM technology, underscoring that broader type 2 populations, particularly those not on intensive insulin regimens, remain underrepresented¹.

iGlucose Touch reinforces the value of connected blood glucose monitoring (BGM) as a proven, accessible option, especially for patients who benefit from simple, on-demand testing without sensors or wearables. It gives providers the flexibility to personalize glucose monitoring strategies while maintaining consistent, real-time data flow across RPM programs.

Seamless Integration into the Smart Meter Cellular RPM™ Ecosystem

iGlucose Touch integrates seamlessly into Smart Meter’s end-to-end Cellular RPM ecosystem, which includes multicarrier SIM devices, platform reliability, access to onboarding and patient engagement services, and connection through the only trusted Private Data Network for RPM in the U.S. This unified approach reduces patient friction, improves adherence, and enables scalable, sustainable RPM programs.

For more information on iGlucose Touch, visit SmartMeterRPM.com/iGlucoseTouch.

About Smart Meter

Since 2016, customers have hired Smart Meter to help solve one of healthcare’s most critical challenges: getting accurate patient vitals to where they need to go securely and reliably every time. Today, Smart Meter is the number one trusted supplier of cellular-enabled remote patient monitoring solutions, delivering reliable, real-time patient data to healthcare providers, payers, and technology partners. With millions of vitals transmitted via its exclusive private data network for RPM, Smart Meter empowers organizations to securely improve patient outcomes, reduce hospitalizations, and optimize reimbursement. For more information, visit SmartMeterRPM.com.

Sources:

1 Littrell, Austin. “The State of Type 2 Diabetes Care in 2025.” Medical Economics, 23 June 2025, https://www.medicaleconomics.com/view/the-state-of-type-2-diabetes-care-in-2025. Accessed 30 Dec. 2025.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260120102929/en/